INS and gestational diabetes: During the subclinical phase, elevated amniotic fluid insulin concentrations in the mid-trimester (OR 1.9, 95% CI 1.3 - 2.4) (3), the maternal metabolic profile during the first trimester (4–7), and the proteomics profile in the first trimester (8–12) are all associated with increased risk of GDM.